Trial Profile
A phase II trial of IW-1973 in patients with resistant hypertension
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 16 Mar 2017
Price :
$35
*
At a glance
- Drugs Praliciguat (Primary)
- Indications Resistant hypertension
- Focus Therapeutic Use
- 16 Mar 2017 New trial record
- 09 Mar 2017 According to an Ironwood Pharmaceuticals media release, this trial is expected to initiate in the second half of 2017.